Emmessar Biotech & Nutrition

quarterly
yearly
ParticularsDec '22Mar '23Jun '23Sep '23Dec '23
Revenue0.870.740.530.610.86
Expenses0.620.490.370.320.56
EBITDA0.270.260.180.310.31
EBIT0.250.240.160.290.29
Profit Before Tax0.250.240.150.290.30
Net Profit-0.020.200.050.200.13
Financial Ratios
Operating Profit Margin62.79%81.25%257.14%387.50%96.97%
Net Profit Margin-4.65%62.50%71.43%250.00%39.39%
Earning Per Share (Diluted)-0.040.380.110.390.26
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.8.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ